(Reuters) - Tetraphase Pharmaceuticals Inc said its experimental bowel drug failed to meet the main goal of a late-stage study.
Latest health news from http://reuters.us.feedsportal.com/c/35217/f/654207/s/49ad6c6f/sc/14/l/0L0Sreuters0N0Carticle0C20A150C0A90C0A80Cus0Etetraphase0Estudy0EidUSKCN0AR82JJ20A150A90A80DfeedType0FRSS0GfeedName0FhealthNews/story01.htm
No comments:
Post a Comment